BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6141738)

  • 1. Inhibitory effect of plasma free fatty acids on glucose production in the conscious dog.
    Wolfe RR; Shaw JH
    Am J Physiol; 1984 Feb; 246(2 Pt 1):E181-6. PubMed ID: 6141738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of kinetics of integrated metabolic response to adrenergic blockade in conscious dogs.
    Wolfe RR; Durkot MJ; Wolfe MH
    Am J Physiol; 1981 Nov; 241(5):E385-95. PubMed ID: 6118065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of epinephrine infusion and adrenergic blockade on glucose oxidation in conscious dogs.
    Wolfe RR; Shaw JH
    Metabolism; 1986 Jul; 35(7):673-8. PubMed ID: 3523120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The integrated effect of adrenergic blockade on glucose, fatty acid, and glycerol kinetics: responses in the basal state and during hormonal control with somatostatin-hormonal infusion.
    Shaw JH; Wolfe RR
    J Surg Res; 1987 Mar; 42(3):257-72. PubMed ID: 2881026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.
    Rebrin K; Steil GM; Mittelman SD; Bergman RN
    J Clin Invest; 1996 Aug; 98(3):741-9. PubMed ID: 8698866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of beta-hydroxybutyrate infusion on glucose and free fatty acid metabolism in dogs.
    Shaw JH; Wolfe RR
    Am J Physiol; 1984 Dec; 247(6 Pt 1):E756-64. PubMed ID: 6095672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fatty acids on glucose production and utilization in man.
    Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
    J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of alpha- and beta-receptors to ketogenic and lipolytic effects of norepinephrine in humans.
    Keller U; Weiss M; Stauffacher W
    Diabetes; 1989 Apr; 38(4):454-9. PubMed ID: 2538376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans.
    Lewis GF; Vranic M; Giacca A
    Am J Physiol; 1998 Jul; 275(1):E177-86. PubMed ID: 9688888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy and substrate kinetics and oxidation during ketone infusion in septic dogs: role of changes in insulin and glucagon.
    Shaw JH; Wolfe RR
    Circ Shock; 1984; 14(1):63-79. PubMed ID: 6149025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamines in prevention of hypoglycemia during exercise in humans.
    Marker JC; Hirsch IB; Smith LJ; Parvin CA; Holloszy JO; Cryer PE
    Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose and FFA kinetics in sepsis: role of glucagon and sympathetic nervous system activity.
    Wolfe RR; Shaw JH
    Am J Physiol; 1985 Feb; 248(2 Pt 1):E236-43. PubMed ID: 3881989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin.
    Mittelman SD; Bergman RN
    Am J Physiol Endocrinol Metab; 2000 Sep; 279(3):E630-7. PubMed ID: 10950832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulation of basal pancreatic polypeptide levels in dogs.
    Werther GA; Sperling MA; Joffe S; Murphy RF
    Regul Pept; 1987 Apr; 17(4):191-8. PubMed ID: 2884699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta adrenergic receptors mediated effects, insulin and plasma free fatty acids in the duck.
    Gross R; Mialhe P
    Horm Metab Res; 1982 Jan; 14(1):18-25. PubMed ID: 6120887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of beta-adrenergic mechanisms during exercise in poorly controlled diabetes.
    Wasserman DH; Lickley HL; Vranic M
    J Appl Physiol (1985); 1985 Oct; 59(4):1282-9. PubMed ID: 2865246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of somatostatin secretion in man: study of the role of free fatty acids and ketone bodies.
    Beylot M; Chayvialle JA; Riou JP; Souquet JC; Sautot G; Cohen R; Mornex R
    Metabolism; 1984 Nov; 33(11):988-93. PubMed ID: 6149447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.